Skip to content

DOuble tasK Test On ergometeR - Basic Research on Acceptability and Use

DOuble tasK Test On ergometeR - Basic Research on Acceptability and Use

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03800771
Acronym
DOKTORBRAU
Enrollment
60
Registered
2019-01-11
Start date
2019-08-28
Completion date
2022-05-17
Last updated
2022-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly Patients

Keywords

geriatric, dual-task, ergometer

Brief summary

The goal of the study is to show the concordance between the dual-task test achieved usually on an electronic treadmill and the dual-task test achieved with a cyclo-ergometer.

Detailed description

Usually, dual task tests are only achieved on electronic treadmills. Patients who are coming to perform these tests are mainly subjects with various levels of cognitive disorders and with a high risk of fall because of potential motor and cognitive disorders. The investigator will select patients referred for double task walking tests. After the walking test, investigator will perform dual-task tests with a new bicycle device Cycléo BRAU which allows the patients to achieve mental tasks while cycling. The aim of using a bicycle is to limit the risk of falls compared to the treadmill or walking task. The Cycléo BRAU device is equiped with a video projector which projects an environment of virtual reality. It allows cycling without resistence and thus is not based on any incremental worload. The mental tasks on bicycle will be of increasing difficulty and parameters such as cycling speed will be recorded. Loss of speed regularity will be considered as an abnormal response. The task for which cycling is stopped will be recorded and compared to the results of the usual walking test.

Interventions

DEVICECycléo BRAU

Practice dual-task tests.

DEVICEGAITRITE®

Routine practice dual-task tests.

Sponsors

University Hospital, Angers
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

Patients are inhomogeneous in term of cognitive and physical function. The aim is to test faisability and security thus investigator will include a relatively large amount of patients.

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 60 years old * Patient with a near visual acuity upper or equal to 2/10 * Patient with a score of MMSE upper than 10 * Patient able to walk on a treadmill for 15 meters on straight line without help * Patient covered by the French health insurance * Patient (or support person or legal representative) able to understand the protocol * Patient (or support person or legal representative) agrees to be involve in the protocol and sign the consent form

Exclusion criteria

* Patient has a wash-out period for another clinical trial * Patient with a medical contraindication to practice bicycle * Patient with locomotor disorders preexisting, whatever the reason * Patient needing extern help to walk like a walking frame, rollator or tricycle * Patient with a medical or surgical disease acute from less of 3 months * Patient with cerebrovascular accident history or any other cerebro-medullary diseases with sensorimotor consequences * Patient with severe depression (Geriatric Depression Scale 15 items upper than 10) * Patient with a low proficiency of French (oral or written)

Design outcomes

Primary

MeasureTime frameDescription
Speed12 monthsEvaluate the concordance of the speed during the tests on treadmill and on cyclo-ergometer.
Speed variability12 monthsEvaluate the concordance the speed variability during the tests on treadmill and on cyclo-ergometer.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026